4,138 results on '"Irwin, David"'
Search Results
202. Digital markers of motor speech impairments in spontaneous speech of patients with ALS-FTD spectrum disorders
203. ATN Cerebrospinal Fluid Biomarkers in Dementia with Lewy Bodies: Initial Results from the United States Dementia with Lewy Bodies Consortium
204. Shared and disparate transcriptomic signatures associated with cortical atrophy change in genetic behavioral variant frontotemporal degeneration
205. Use of α‐synuclein seed amplification assays to assess how clinical features relate to the diagnosis of Dementia with Lewy Bodies
206. Quantifying associations of four major proteinopathies with grey matter atrophy: an imaging‐pathology study
207. CSF proteomics in autosomal dominant Alzheimer’s disease highlights parallels with sporadic disease
208. Identifying microglial CSF biomarkers specifically dysregulated in either the preclinical or the dementia stage of Alzheimer’s disease
209. Plasma glial fibrillary acidic protein is associated with concomitant brain β‐amyloid in Lewy body disease
210. Automatic classification of underlying AD vs. FTLD pathology in people with clinical Frontotemporal Dementia using digital speech markers
211. Evaluation of quantitative measurements of tau pathology with semi‐quantitative ratings and age
212. Developing an anatomically valid segmentation protocol for early tau regions: the anterior medial temporal lobe cortices
213. T1 MRI reveals differential hippocampal atrophy in Lewy Body Disorders with and without Alzheimer’s copathology
214. A multivariate MRI model of Alzheimer’s disease risk is associated with clinical diagnosis, PET imaging, and plasma biomarkers in a mixed dementia sample
215. Automated analysis of letter fluency data produced by Korean and American patients with AD and MCI
216. Identification of Hippocampal and Amygdala Subfields Predictive of MoCA Scores in Patients with Dementia with Lewy Bodies
217. CSF proteome profiling identifies novel biomarkers for Frontotemporal Dementia and its pathological subtypes
218. Using an ex vivo MRI atlas of the human medial temporal lobe to characterize the 3D distribution of neurofibrillary tangle burden across histologically defined subregions
219. Pyramidal neurodegeneration is linked to select cytoarchitecture and cognitive impairment in behavioral variant frontotemporal dementia with tau or TDP‐43 pathology
220. Tau maturation in clinicopathological spectrum of Lewy body and Alzheimer’s disease
221. Polypathologic associations with grey matter atrophy in neurodegenerative disease
222. Genomic evolution of island birds from the view of the Swinhoe's pheasant (Lophura swinhoii)
223. Racial Differences in Clinical Presentation in Individuals Diagnosed With Frontotemporal Dementia
224. WattScope: Non-intrusive application-level power disaggregation in datacenters
225. Degeneration of the locus coeruleus is a common feature of tauopathies and distinct from TDP-43 proteinopathies in the frontotemporal lobar degeneration spectrum
226. Differences in the gut microbiomes of dogs and wolves: roles of antibiotics and starch
227. Lewy Body Dementia Association’s Industry Advisory Council: proceedings of the second annual meeting
228. AutoShare: Virtual community solar and storage for energy sharing
229. Retina tissue validation of optical coherence tomography determined outer nuclear layer loss in FTLD-tau
230. Decoding the RNA viromes in rodent lungs provides new insight into the origin and evolutionary patterns of rodent-borne pathogens in Mainland Southeast Asia
231. Frontotemporal lobar degeneration proteinopathies have disparate microscopic patterns of white and grey matter pathology
232. Defining and predicting transdiagnostic categories of neurodegenerative disease
233. P3‐309: Advancing research and treatment of frontotemporal lobar degeneration (ARTFL): Preparing for clinical trials for ftld in north america
234. SNP genotyping using TaqMan technology: the CYP2D6*17 assay conundrum.
235. Evolution of Trichocyte Keratin Associated Proteins
236. Wheelchair Rugby
237. Ultrasound-Guided Lumbar Facet Nerve Block and Intra-articular injection
238. African Approaches to Dialogue and Advocacy
239. A longitudinal study of speech production in primary progressive aphasia and behavioral variant frontotemporal dementia
240. Outcome Measures for Dementia With Lewy Body Clinical Trials: A Review
241. Are there two visual short-term memory stores? A state-trace analysis
242. An examination of genes, stress and suicidal behavior in two First Nations communities: The role of the brain-derived neurotropic factor gene
243. UNC13A polymorphism contributes to frontotemporal disease in sporadic amyotrophic lateral sclerosis
244. Rates of lobar atrophy in asymptomatic MAPT mutation carriers
245. Elevated CSF GAP-43 is Alzheimer's disease specific and associated with tau and amyloid pathology
246. The longitudinal evaluation of familial frontotemporal dementia subjects protocol: Framework and methodology
247. Individualized atrophy scores predict dementia onset in familial frontotemporal lobar degeneration
248. Use of the CDR® plus NACC FTLD in mild FTLD: Data from the ARTFL/LEFFTDS consortium
249. Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint
250. A tribute to John Q. Trojanowski (1946-2022)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.